Joint Linkage and Association Analysis with Exome Sequence Data Implicates SLC25A40 in Hypertriglyceridemia

详细信息    查看全文

• 作者：Elisabeth聽A. Rosenthal ; Jane Ranchalis ; David聽R. Crosslin ; Amber Burt ; John聽D. Brunzell ; Arno聽G. Motulsky ; Deborah聽A. Nickerson ; NHLBI GO Exome Sequencing Project ; Ellen聽M. Wijsman ; Gail聽P. Jarvik
• 刊名：The American Journal of Human Genetics
• 出版年：5 December, 2013
• 年：2013
• 卷：93
• 期：6
• 页码：1035-1045
• 全文大小：241 K

文摘

Hypertriglyceridemia (HTG) is a heritable risk factor for cardiovascular disease. Investigating the genetics of HTG may identify new drug targets. There are 鈭?5 known single-nucleotide variants (SNVs) that explain only 鈭?0% of variation in triglyceride (TG) level. Because of the genetic heterogeneity of HTG, a family study design is optimal for identification of rare genetic variants with large effect size because the same mutation can be observed in many relatives and cosegregation with TG can be tested. We considered HTG in a five-generation family of European American descent (n = 121), ascertained for familial combined hyperlipidemia. By using Bayesian Markov chain Monte Carlo joint oligogenic linkage and association analysis, we detected linkage to chromosomes 7 and 17. Whole-exome sequence data revealed shared, highly conserved, private missense SNVs in both SLC25A40 on chr7 and PLD2 on chr17. Jointly, these SNVs explained 49% of the genetic variance in TG; however, only the SLC25A40 SNV was significantly associated with TG (p = 0.0001). This SNV, c.374A>G, causes a highly disruptive p.Tyr125Cys substitution just outside the second helical transmembrane region of the SLC25A40 inner mitochondrial membrane transport protein. Whole-gene testing in subjects from the Exome Sequencing Project confirmed the association between TG and SLC25A40 rare, highly conserved, coding variants (p = 0.03). These results suggest a previously undescribed pathway for HTG and illustrate the power of large pedigrees in the search for rare, causal variants.